SAN CLEMENTE, CA November 17, 2010 – SURFER Magazine is proud to announce this year’s SURFER Poll Agent of Change Award to James Dunlop (Executive Director of MOF) and Charles Dunlop (CEO of Ambry Genetics), founders of the Mauli Ola Foundation (MOF). The Foundation will benefit from the proceeds of VIP table sales, and their…

Aliso Viejo, CA, September 9, 2010 – Roche NimbleGen (SIX: RO, ROG; OTCQX: RHHBY) announces that Southern California (Aliso Viejo) based genomic services provider Ambry Genetics has officially become a Certified Service Provider (CSP) for the NimbleGen SeqCap EZ Exome workflow. They will provide target-enrichment services using NimbleGen SeqCap EZ Human Exome coupled with next-generation…

Aliso Viejo, CA – August 25, 2010 – Ambry Genetics, a global leader in genomic services, announced today that it has acquired the Illumina HiSeq 2000 Next Generation Sequencing System as well as received the first 510(K) approved Illumina BeadXpress Genotyping System. Ambry Genetics has been an early adapter of Illumina systems since late 2007…

ALISO VIEJO, CA, March 23, 2010 – Ambry Genetics today introduced The Ambry X-Linked Intellectual Disabilities SuperPANEL™, a suite of genetic tests expected to pinpoint the cause of intellectual disability and X-Linked Intellectual Disabilities (XLMR). This panel marks the first time next generation sequencing technology, coupled with microarrays, Sanger sequencing and traditional Fragile X testing,…

ALISO VIEJO, CA, March 17, 2010 – Ambry Genetics and RainDance Technologies today jointly announced at the Annual CHI Next Generation Sequencing Conference in San Diego, CA their partnership utilizing the RDT 1000 for sequence enrichment and resequencing validation. A global leader for genetic testing and next generation sequencing services, Ambry Genetics is a CLIA…

Aliso Viejo, CA, January 20, 2010 – Ambry Genetics today introduces their new StemArray™ product and services utilizing aCGH technology to cover the entire genome. The Ambry StemArray™ offers a higher resolution approach to standard karyotyping for stem cells at comparable costs. The 44K array offers increased coverage in known stem cell and cancer associated…

Aliso Viejo, CA and State College, PA: December 3, 2009 – Ambry Genetics and SoftGenetics today announced the signing of an agreement to provide extended bioinformatics genomics services using SoftGenetics’ NextGENe® Software for next-generation sequencing projects performed at Ambry Genetics. Anja Kammesheidt PhD, Ambry’s CSO said, “Our team at Ambry has been providing genomics solutions…

Aliso Viejo & Santa Clara, CA: October 22, 2009 – Ambry Genetics and Agilent Technologies Inc. (NYSE: A) today announced that Ambry is the first organization to achieve Certified Service Provider (CSP) status for Agilent’s SureSelect Target Enrichment System for next-generation sequencing. SureSelect, introduced in February 2009, has been shown to greatly increase the speed…

Aliso Viejo, CA, September 1, 2009 – Ambry Genetics announced today that they have completed certification to become an Agilent Certified Service Provider on the Agilent MicroArray platform. The initial certification is for Comparative Genomic Hybridization (aCGH) which is an application used by researchers to discover and detect genomic copy number variations within specific genomes.…

Aliso Viejo, CA, June 3, 2009 – Ambry Genetics is pleased to announce the launch of whole-genome Chromosomal Microarray Analysis (CMA), offering the Ambry CMA: 105K Oligo Array, which is designed to identify chromosomal abnormalities associated with over 270 genetic disorders. In a partnership with Baylor College of Medicine, Ambry is now able to provide…